Cargando…
Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide(®))
Autores principales: | Tjon Pian Gi, Robin E. A., Dietz, Andreas, Djukic, Vojko, Eckel, Hans E., Friedrich, Gerhard, Golusinski, Wojciech, Hantzakos, Anastasios, Lawson, George, Remacle, Marc, Rihkanen, Heikki, Dikkers, Frederik G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259328/ https://www.ncbi.nlm.nih.gov/pubmed/22020697 http://dx.doi.org/10.1007/s00405-011-1804-7 |
Ejemplares similares
-
Side-effects of cidofovir in the treatment of recurrent respiratory papillomatosis
por: Broekema, Ferdinand I., et al.
Publicado: (2008) -
Recurrent respiratory papillomatosis by HPV: review
of the literature and update on the use of cidofovir
por: FUSCONI, M., et al.
Publicado: (2014) -
Recurrent respiratory papillomatosis: the role of cidofovir
por: Tran, Mai Ngoc, et al.
Publicado: (2018) -
Efficacy of cidofovir in recurrent juvenile respiratory papillomatosis
por: Valera, Fabiana, et al.
Publicado: (2015) -
Effectiveness of cidofovir intralesional treatment in recurrent respiratory papillomatosis
por: Wierzbicka, Małgorzata, et al.
Publicado: (2011)